Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory ...

Chronic inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, cause recurring diarrhea, fever, ...

UC is a type of inflammatory bowel disease (IBD) that affects the large intestine and rectum. Treatment involves Diabetes is a group of metabolic ... decreased bone density, and changes in the ...

Scores on a broad panel of blood metabolomic markers may predict inflammatory bowel disease (IBD) up to 10 years before onset, indicated a new study that leveraged population data from three ...

Not just because she's a well-educated, pediatric endocrinologist and metabolic bone disorder specialist at Phoenix Children’s Hospital. But because the 41-year-old physician has the disease ...

Together, these results suggest a promising new therapeutic strategy for managing IBD and increasing long ... we are pursuing alongside our metabolic disease-focused clinical and preclinical ...

an oral investigational med that the biotech was assessing in a phase 2/3 IBD trial and touted as phase 2-ready in liver fibrosis. The asset also has potential applications in metabolic diseases ...

Although there are effective drugs for treating this metabolic bone disease, they can be expensive and have side effects, limiting their availability to some people. In the search for alternative ...

This observation was consistent with previous studies that documented an increased risk of metabolic syndrome and cardiovascular disease in IBD patients. The sub-group analysis indicated a higher ...